MedTrace Logo

Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas

NCT04006236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 245

Last updated 2021-09-24

No results posted yet for this study

Summary

This is a randomized, controlled, double-blind, multicenter parallel study to evaluate the growth, tolerance and compliance of healthy infants fed infant formulas with extensively hydrolyzed casein protein.

Conditions

  • Infant Development

Interventions

OTHER

Experimental Infant Formula

Feed Ad Libitum

OTHER

Control Infant Formula

Feed Ad Libitum

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Carlett Ramirez · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
0 Days
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-05
Primary Completion
2021-09-20
Completion
2021-09-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04006236 on ClinicalTrials.gov